noad

Regen Therapeutics News (LSE:RGT)

Latest Regen Therapeutics News Headlines
DateTimeSource
Headline
11/10/20082:01AMUKREGIssue of Shares
RNS Number : 7655H ReGen Therapeutics PLC 10 November 2008... More...>>
11/04/20088:10AMUKREGShareholding
RNS Number : 4034H ReGen Therapeutics PLC 04 November 2008 4th November 2008 REGEN THERAPEUTICS PLC ("ReGen" or the "Company"; Ticker: (RGT)) TR-1(i): NOTIFICATION OF MAJOR INTEREST IN SHARES 1.Identity of the issuer or the underlying issuer of existing shares to which... More...>>
10/31/20086:56AMUKREGTotal Voting Rights
RNS Number : 1385H ReGen Therapeutics PLC 31 October 2008 Immediate Release 31 October 2008 ReGen Therapeutics Plc ('ReGen' or the Company') Total Voting Rights For the purposes of the Disclosure and Transparency Rules of the Financial Services Authority, the Board of... More...>>
10/31/20086:56AMUKREGTotal Voting Rights
RNS Number : 1385H ReGen Therapeutics PLC 31 October 2008 Immediate Release 31 October 2008 ReGen Therapeutics Plc ('ReGen' or the Company') Total Voting Rights For the purposes of the Disclosure and Transparency Rules of the Financial Services Authority, the Board of... More...>>
10/27/20083:00AMUKREGIssue of Equity
RNS Number : 6970G ReGen Therapeutics PLC 27 October 2008... More...>>
10/13/200812:19PMUKREGSignificant Shareholding
RNS Number : 7521F ReGen Therapeutics PLC 13 October 2008 13 October 2008 REGEN THERAPEUTICS PLC ("ReGen" or the "Company"; Ticker: (RGT)) TR-1(i): NOTIFICATION OF MAJOR INTEREST IN SHARES 1.Identity of the issuer or the underlying issuer of existing shares to which voting... More...>>
10/09/200810:59AMUKREGHolding(s) in Company
RNS Number : 5145F ReGen Therapeutics PLC 09 October 2008 9 October 2008 REGEN THERAPEUTICS PLC ("ReGen" or the "Company"; Ticker: (RGT)) TR-1(i): NOTIFICATION OF MAJOR INTEREST IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to... More...>>
10/09/20083:10AMTFNFRegen Therapeutics launches Colostrinin in Cyprus
ReGen Therapeutics Plc. said it has launched Colostrinin, which supports healthy brain aging and cognition, in Cyprus. tf.TFN-Europe_newsdesk@thomsonreuters.com ypv/ra COPYRIGHT Copyright Thomson Financial News Limited 2008. All rights reserved. The copying, republication or redistribution... More...>>
10/09/20082:00AMUKREGEuropean Launch of Colostrinin in Cyprus
RNS Number : 3649F ReGen Therapeutics PLC 09 October 2008 Embargoed for 7am Thursday 9th October 2008 ReGen Therapeutics Plc First launch of ColostrininTM in European Union by Golgi Pharmaceuticals Ltd in the Republic of Cyprus. ReGen Therapeutics Plc ('ReGen... More...>>
10/06/20087:52AMUKREGGeneral Meeting, Share Capital Sub-division
RNS Number : 1609F ReGen Therapeutics PLC 06 October 2008 For immediate release 6 October 2008 ReGen Therapeutics Plc Results of General Meeting and Sub-division of Share Capital ReGen Therapeutics Plc (the 'Company') announces that, at the General Meeting of the Company held... More...>>
10/06/20083:20AMTFNFReGen Therapeutics says encouraged by Pretoria study into Zolpidem response
ReGen Therapeutics Plc. said the recent trial of its Zolpidem drug shows the drug can help a considerable number of patients with a wide range of brain damage, from birth injury to trauma, stroke and others. Preliminary results of a study being conducted in South Africa also suggest the proportion responding... More...>>
10/06/20082:00AMUKREGZolpidem Review
RNS Number : 9728E ReGen Therapeutics PLC 06 October 2008 6th October 2008 embargoed for 7am ReGen Therapeutics Plc Review of zolpidem effects after brain damage due to brain trauma, stroke and other causes, presented at 'Magic bullet' Conference ReGen Therapeutics Plc ("ReGen... More...>>
10/02/20089:04AMUKREGSignificant Shareholding
RNS Number : 9552E ReGen Therapeutics PLC 02 October 2008 Immediate Release 2 October 2008 ReGen Therapeutics Plc ('ReGen' or the Company') Significant Shareholding The Company announces that it was today informed that Unokal Ltd and Clariant Foundation on... More...>>
09/30/200810:45AMUKREGTotal Voting Rights
RNS Number : 7308E ReGen Therapeutics PLC 30 September 2008 Immediate Release 30 September 2008 ReGen Therapeutics Plc ('ReGen' or the Company') Total Voting Rights For the purposes of the Disclosure and Transparency Rules of the Financial Services Authority, the Board... More...>>
09/23/200812:29PMUKREGHolding(s) in Company
RNS Number : 1333E ReGen Therapeutics PLC 23 September 2008 23rd September 2008 REGEN THERAPEUTICS PLC (*ReGen* or the *Company*; Ticker: (RGT)) TR-1(i): NOTIFICATION OF MAJOR INTEREST IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to which voting... More...>>
09/23/200812:21PMUKREGHolding(s) in Company
RNS Number : 1317E ReGen Therapeutics PLC 23 September 2008 23rd September 2008 REGEN THERAPEUTICS PLC ("ReGen" or the "Company"; Ticker: (RGT)) TR-1(i): NOTIFICATION OF MAJOR INTEREST IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to... More...>>
09/23/20083:59AMTFNFReGen Therapeutics H1 pretax loss narrows on reduced costs
ReGen Therapeutics Plc. said its first half pretax loss narrowed to 1.12 million pounds from 1.6 million pounds as it restructured its development programme and reduced administrative costs. It said cash administrative costs for the first half fell 17 percent to 668,000 pounds. The actual cash spent during... More...>>
09/23/20082:00AMUKREGInterim Results
RNS Number : 0312E ReGen Therapeutics PLC 23 September 2008 REGEN THERAPEUTICS PLC 23 September 2008 UNAUDITED INTERIM RESULTS FOR THE SIX MONTHS TO 30 JUNE 2008 ReGen Therapeutics Plc ('ReGen... More...>>
09/15/20084:22AMTFNFReGen Therapeutics raises 110,000 pounds after share subscriptions
ReGen Therapeutics Plc. said it has raised 110,000 pounds before expenses after Headstart Group of Funds subscribed for about 1.1 million shares in the company at 10 pence each and a long term shareholder subscribed a further 100,000 shares at the same price. The company had entered into a 2 million pounds... More...>>
09/15/20082:00AMUKREGIssue of Equity
RNS Number : 3882D ReGen Therapeutics PLC 15 September 2008 15 September 2008 ReGen Therapeutics Plc Issue of Shares As announced by ReGen Therapeutics Plc ("ReGen" or the "Company"), (AIM: RGT) on 14 September 2005, ReGen had entered into a £2,000,000 equity credit facility... More...>>


LSE and PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright1999-2008 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
ADDITIONAL SERVICES AVAILABLE FROM ADVFN
Upgrade - Click here for more information on ADVFN premium services Money Words - ADVFN Financial Glossary Investor Training ADVFN Financial Bookshop Online Training Academy
31 site:2us lse rgt081122 14:58 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2005 | 2007 )